NCT03316976View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 22, 2017

Primary Completion Date

February 8, 2018

Study Completion Date

February 8, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Dexlansoprazole

Dexlansoprazole delayed-release capsule.

Trial Locations (1)

100005

Phase I Clinical Trial Department, Beijing

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY